The combined efforts of researchers, investors, and pharmaceutical and biotech companies have resulted in substantial progress in the treatment of major diseases such as cancer, diabetes, a
Alto Neuroscience has said its therapeutic approach to depression of matching patients to drugs based on brain biomarkers has shown promise in a phase 2a trial.
Verily, an Alphabet precision health tech company, and L’Oréal, a leading household name in beauty, have announced the launch of the ‘My Skin & Hair Journey’ – a multi-year study to ena
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year